About (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide
(3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide (PubChem CID 166025589) has the molecular formula C32H35F3N4O3S
and a molecular weight of 612.72 g/mol. Its IUPAC name is (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide.
Molecular Properties
| Compound Name | (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide |
| PubChem CID | 166025589 |
| Molecular Formula | C32H35F3N4O3S |
| Molecular Weight | 612.72 g/mol |
| Exact Mass | 612.24 |
| IUPAC Name | (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide |
| SMILES | Cc1ccc(S(=O)(=O)n2ncc3cc(C[C@@H](CNC(=O)C[C@@H](c4ccccc4)C4(C(F)(F)F)CC4)N(C)C)ccc32)cc1 |
| InChI | InChI=1S/C32H35F3N4O3S/c1-22-9-12-27(13-10-22)43(41,42)39-29-14-11-23(17-25(29)20-37-39)18-26(38(2)3)21-36-30(40)19-28(24-7-5-4-6-8-24)31(15-16-31)32(33,34)35/h4-14,17,20,26,28H,15-16,18-19,21H2,1-3H3,(H,36,40)/t26-,28-/m0/s1 |
| InChIKey | KIOCFGHQHGGRIZ-XCZPVHLTSA-N |
| XLogP | 5.69 |
| TPSA | 84.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 612.72 |
| LogP ≤ 5 | 5.69 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide?
The IUPAC name of (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide (CID 166025589) is (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide.
What is the SMILES notation for (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide?
The canonical SMILES for (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide is Cc1ccc(S(=O)(=O)n2ncc3cc(C[C@@H](CNC(=O)C[C@@H](c4ccccc4)C4(C(F)(F)F)CC4)N(C)C)ccc32)cc1.
What is the InChIKey of (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide?
The InChIKey is KIOCFGHQHGGRIZ-XCZPVHLTSA-N. The full InChI is InChI=1S/C32H35F3N4O3S/c1-22-9-12-27(13-10-22)43(41,42)39-29-14-11-23(17-25(29)20-37-39)18-26(38(2)3)21-36-30(40)19-28(24-7-5-4-6-8-24)31(15-16-31)32(33,34)35/h4-14,17,20,26,28H,15-16,18-19,21H2,1-3H3,(H,36,40)/t26-,28-/m0/s1.
What are the key properties of (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide?
(3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide has a molecular weight of 612.72 g/mol, XLogP of 5.69, 11 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]-3-phenyl-3-[1-(trifluoromethyl)cyclopropyl]propanamide is sourced from PubChem (CID 166025589), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).